<DOC>
	<DOCNO>NCT00633932</DOCNO>
	<brief_summary>This study evaluate efficacy esomeprazole 20 mg daily 40 mg daily 8 week heal Reflux Esophagitis patient reflux esophagitis comparison omeprazole 20 mg daily assessment presence/absence Reflux Esophagitis Week 8 accord Los Angeles classification .</brief_summary>
	<brief_title>Reflux Esophagitis Phase III Study ( Initial Treatment )</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esophagitis , Peptic</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Endoscopically verify Reflux Esophagitis classify Los Angeles classification Grade A , B , C D within 1 week randomisation Gastric duodenal ulcer verify EGD within 12 week randomisation . Use PPI 14 day EGD perform screen visit day randomisation .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Reflux Esophagitis</keyword>
</DOC>